156 related articles for article (PubMed ID: 27487102)
1. Highlights in kidney cancer from the 2016 American Society of Clinical Oncology Annual Meeting.
Clin Adv Hematol Oncol; 2016 Aug; 14(8):594-6. PubMed ID: 27487102
[No Abstract] [Full Text] [Related]
2. Highlights in kidney cancer from the 2017 American Society of Clinical Oncology Annual Meeting.
Clin Adv Hematol Oncol; 2017 Sep; 15(9):682-683. PubMed ID: 28949939
[No Abstract] [Full Text] [Related]
3. Cabozantinib approved for first-line treatment of advanced renal cell carcinoma.
Clin Adv Hematol Oncol; 2018 Feb; 16(2):96. PubMed ID: 29741507
[No Abstract] [Full Text] [Related]
4. Highlights in breast cancer from the 2016 American Society of Clinical Oncology Annual Meeting.
Rugo HS
Clin Adv Hematol Oncol; 2016 Jul; 14(7):494-7. PubMed ID: 27379943
[No Abstract] [Full Text] [Related]
5. The 'nivolution' in renal cell carcinoma: behind the scenes of clinical trials.
Buti S; Bersanelli M
Future Oncol; 2016 Sep; 12(18):2061-3. PubMed ID: 27168416
[No Abstract] [Full Text] [Related]
6. Highlights in Metastatic Prostate Cancer From the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: Commentary.
Shore ND
Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 5):17-9. PubMed ID: 27167847
[No Abstract] [Full Text] [Related]
7. Clinical use of checkpoint inhibition in kidney cancer.
Clin Adv Hematol Oncol; 2016 Jun; 14(6):427-9. PubMed ID: 27379812
[No Abstract] [Full Text] [Related]
8. Current and emerging first-line systemic therapies in clear cell renal cell carcinoma.
Rini BI
Clin Adv Hematol Oncol; 2018 Feb; 16(2):115-117. PubMed ID: 29741511
[No Abstract] [Full Text] [Related]
9. Highlights in GEP-NETs From the 2015 American Society of Clinical Oncology Annual Meeting.
Clin Adv Hematol Oncol; 2015 Aug; 13(8 Suppl 8):1-19. PubMed ID: 26431403
[No Abstract] [Full Text] [Related]
10. Axitinib in metastatic renal cell carcinoma: beyond the second-line setting.
Umeyama Y; Shibasaki Y; Akaza H
Future Oncol; 2017 Sep; 13(21):1839-1852. PubMed ID: 28707479
[TBL] [Abstract][Full Text] [Related]
11. Highlights from the 42nd Annual Meeting of the American Society of Clinical Oncology, Atlanta, GA; June 2-6, 2006.
Reddy GK; Tyagi P
Clin Genitourin Cancer; 2006 Jun; 5(1):18-22. PubMed ID: 16859574
[No Abstract] [Full Text] [Related]
12. Highlights of the American Society of Clinical Oncology annual meeting 2005. 13-17 May, 2005, Florida, USA.
Burstein HJ
Expert Rev Anticancer Ther; 2005 Aug; 5(4):581-3. PubMed ID: 16111459
[No Abstract] [Full Text] [Related]
13. [Systemic therapy for metastatic renal cell carcinoma].
Kramer MW; Steffens S; von Klot C; Merseburger AS; Kuczyk MA
Aktuelle Urol; 2012 Jul; 43(4):265-8. PubMed ID: 22869498
[TBL] [Abstract][Full Text] [Related]
14. [ASCO 2006: temsirolimus increases survival].
Aktuelle Urol; 2006 Sep; 37(5 Suppl):12. PubMed ID: 23646393
[No Abstract] [Full Text] [Related]
15. Targeted Agents for the Frontline Management of Chronic Lymphocytic Leukemia.
Burger JA
Clin Adv Hematol Oncol; 2016 May; 14(5 Suppl 8):7-12. PubMed ID: 27168204
[No Abstract] [Full Text] [Related]
16. Chemotherapy for advanced renal-cell carcinoma: 1983-1993.
Yagoda A; Abi-Rached B; Petrylak D
Semin Oncol; 1995 Feb; 22(1):42-60. PubMed ID: 7855619
[No Abstract] [Full Text] [Related]
17. Targeted therapy for the adjuvant treatment of stage III BRAF-mutated melanoma.
Long G
Clin Adv Hematol Oncol; 2018 Jan; 16(1):25-27. PubMed ID: 29741501
[No Abstract] [Full Text] [Related]
18. Summary of a joint meeting between the Southwest Oncology Group and the Japanese clinical trials consortium.
Rothenberg ML; Coltman CA; Fukushima M
J Cancer Res Clin Oncol; 1993; 119(9):564-7. PubMed ID: 8325905
[No Abstract] [Full Text] [Related]
19. Lenvatinib therapy for the treatment of patients with advanced renal cell carcinoma.
Glen H
Future Oncol; 2016 Oct; 12(19):2195-204. PubMed ID: 27339111
[TBL] [Abstract][Full Text] [Related]
20. Management of poor-risk metastatic renal cell carcinoma: current approaches, the role of temsirolimus and future directions.
Porta C; Tortora G; Larkin JM; Hutson TE
Future Oncol; 2016 Feb; 12(4):533-49. PubMed ID: 26606910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
